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Background: Protothecosis is an uncommon human infection caused by Prototheca. Prototheca spp can be
considered as saprophytes, and in spite of their frequency in the environment, they are of low virulence
and may cause chronic infection with low-grade inﬂammation in humans. At present, only three species
are recognized: Prototheca wickerhamii, Prototheca zopﬁi and Prototheca stagnora. Of these, the former
two have been associated with human disease. This study was an investigation of the clinical and
microbiological features of a case of granulomatous lymphadenitis due to P. zopﬁi var. portoricensis in an
immunocompetent man in China.
Methods: We report the case of a 39-year-old male, who presented with swollen lymph nodes, from
which the organismwas isolated and identiﬁed by the RapidID Yeast Plus test (Remel, Santa Fe, NM, USA)
and PCR molecular analysis. The pathogenicity of the isolate was conﬁrmed in a mouse model and
antifungal drug susceptibility testing was carried out.
Results: The pathogenwas identiﬁed as Prototheca zopﬁi. The DNA sequence of the 18S SSU rDNA regions
of the isolate strain were 100% (1205/1205) identical with Prototheca zopﬁi var. portoricensis. Antifungal
susceptibility tests revealed that it was sensitive to amphotericin B, but resistant to 5-ﬂucytosine,
ﬂuconazole, ketoconazole, and itraconazole. The patient responded to treatment with intravenous
itraconazole and amphotericin B.
Conclusions: Based on the patient’s symptoms and microscopic evaluation, cultures, and molecular
analyses of the isolate, granulomatous lymphadenitis due to P. zopﬁi var. portoricensiswas diagnosed. P.
zopﬁi var. portoricensis as a causative agent of human lymphadenitis in an immunocompetent case has
not been reported, though a few cases of protothecosis have been reported in China. The real number of
protothecosis casesmay be greater than that reported in the literature. Thus, clinicians should be vigilant
for any unknown cause of granulomatous lymphadenitis and should undertake an intensive
histopathology, mycology examination, and even molecular analysis to rule out or conﬁrm a potential
Prototheca infection.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Protothecosis is an uncommon human infection caused by
Prototheca. Prototheca spp can be considered as saprophytes, and in
spite of their frequency in the environment, they are of low
virulence and may cause chronic infection with low-grade§ This paper was presented at the 2009 International Society for Human and
Animal Mycology (ISHAM) Congress, Tokyo, Japan.
* Corresponding author. Tel.: +86 21 52887776; fax: +86 21 52887776.
E-mail address: zhangqq8@163.com (QQ. Zhang).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.10.003inﬂammation in humans. At present, only three species are
recognized: Prototheca wickerhamii, Prototheca zopﬁi, and Proto-
theca stagnora. Of these, the former two have been associated with
human disease.
We report herein the case of a 39-year-old immunocompetent
male presenting with swollen lymph nodes, from which the
uncommon Prototheca zopﬁi var. portoricensis was isolated and
identiﬁed by direct microscopy and culture, conﬁrmed by
histopathology and molecular analysis. The patient responded
well to treatment with intravenous itraconazole and amphotericin
B. This case of systemic protothecosis in which sole lymph nodes
were affected in an immunocompetent host is exceptionally rare.ses. Published by Elsevier Ltd. All rights reserved.
Fig. 2. Histopathology of the lymph node showed spheroid, ovoid cells with a
prominent wall, and these round cells contained several thick-walled endospores,
as detected by PAS stain. The arrows point to sporangium containing autospores.
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A 39-year-old man, employed as an electrician, presented with
swollen lymph nodes in his left neck of 7-month duration, without
obvious cause. The swollen lymph nodes were limited to the local
area and were painless, around 1 cm in size, coalescent in a chain-
shape, and ﬁrm in texture. Examination by B mode ultrasound
scanner showed no enlargement of the lymph nodes in other
regions. The patient was otherwise in good health and had no
symptoms of weight loss, night sweats, fatigue, or prolonged fever;
no predisposing factors associatedwith swollen lymph nodeswere
detected. Physical examination of his heart and lungs revealed no
abnormality. A chest X-ray was normal. Regional ultrasound
diagnosis showed several enlarged lymph nodes in his neck and
above the clavicle. Laboratory tests revealed a white blood cell
count of 5.78  109/l (40.9% of polymorphonuclear leukocytes,
40.7% of lymphocytes, 0.2% mononuclear leukocytes, 6.6% of
eosinophils, 1.6% of basophilic granulocytes) and chloride of
106 mmol/l (normal range 95–105 mmol/l). Routine laboratory
examination revealed normal liver and renal function. Cell-
mediated immune function was assessed using standard CD
markers as analyzed by ﬂow cytometry, and the results showed
normal levels of T, B and NK cells, along with a normal CD8 to CD4
ratio. Normal levels of IgG, IgA, and IgM were observed. Serum
antibody tests for syphilis and HIV were non-reactive. No
involvement of other organs/tissues was evidenced.
Under local anesthetic, an incision biopsy was performed of a
swollen lymph node in his neck. It was interesting to note that
fresh-mount microscopy of the biopsy material showed spherical
sporangia with endospores of 13–22mm in diameter (Fig. 1).
Histopathology showed fungal granuloma with inﬁltrate of giant
cells, conﬁrming the initial ﬁnding. Histopathology showed several
spheroid, ovoid cells with a prominent wall, and these round cells
contained several thick-walled endospores, as detected by periodic
acid-Schiff (PAS) stain (Fig. 2). The biopsymaterial was cultured on
Sabouraud dextrose agar (SDA) plates at 37 8C and 25 8C,
separately, and both cultures grew smooth, creamy white,
yeast-like colonies after 96 h. Microscopic examination revealedFig. 1. Direct microscopic examination of a 10% KOH smear of the excision biopsy of
an enlarged lymph node showed spherical sporangia with sporangiospores. The
arrow points to sporangia.spherical to oval sporangia with many endospores of different
sizes, with a range of 12–16  15–22mm, but no hyphae or
blastospores were found (Fig. 3). No other microorganisms were
isolated in the SDA plates incubated at 25 8C and 37 8C and
Prototheca did not grow on SDA plus cycloheximide at 40 8C. Pink
colonies were found on CHROMagar Candida (CHROMagar Co.,
France). Carbohydrate assimilation tests showed the isolate could
assimilate n-propanol, arginine, dextrose, galactose, and glycerol,
but not sucrose and trehalose. The pathogen was identiﬁed as
Prototheca zopﬁi by RapidID Yeast Plus test (Remel, Santa Fe, NM,
USA); 99.3% probability was obtained by this commercial yeast
identiﬁcation system. Additionally, bacterial and mycobacterial
cultures of the biopsied specimen were negative.
3. Molecular identiﬁcation
Genomic DNA was extracted from 4-day cultures using the
Biospin Fungus Genomic DNA Extraction Kit (BioFlux, Japan),Fig. 3. Colony smear showed spherical to oval sporangia with many
sporangiospores of different sizes.
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was suspended in a lysis buffer and incubated in a 65 8Cwater bath
for 60 min, followed by a simple puriﬁcation procedure to extract
DNA based on the selectivity of the Biospin membrane. SSU rDNA
was ampliﬁed by PCR using eukaryote-speciﬁc primers Eukar
univer 18F (50-AGGGTTCGATTCCGGAG-30) and Eukar univer 18R
(50-ACGGGCGGTGTGTAC-30),1 provided by Shanghai Invitrogen
Biotech Co., Ltd. The PCR was performed in a volume of 50 ml,
including 25 ml of PCR pfuMix (dATP, dCTP, dGTP, dTTP and
pfuDNA Taq polymerase; Beijing Tiangen Biotech Co., Ltd), 2ml of
each of the primers, 19 ml of ddH2O, and 2ml of DNA sample. The
ampliﬁcation was carried out at 95 8C for 5 min, followed by 35
cycles of 94 8C for 60 s, 55 8C for 60 s, and 72 8C for 2 min, with a
ﬁnal extension step at 72 8C for 10 min. The PCR products were
electrophoresed on a 1.2% agarose gel for 30 min in TAE buffer,
stained with GoldView (Beijing SBS Genetech Co., Ltd), and
visualized with UV light. Puriﬁcation and bidirectional sequence
analysis of the PCR products were performed by Invitrogen Life
Technologies.
4. Results
4.1. Results of PCR assay
The target region of SSU rDNA was 1205 bp. The query
sequences were submitted to the BLAST system and aligned with
clustalW analysis. According to the results of BLAST, the closest
match was considered to be the most likely correct identiﬁcation.
The DNA sequence of the 18S SSU rDNA regions of the isolate strain
were 100% (1205/1205) identical with Prototheca zopﬁi var.
portoricensis (accession number FJ358428). However, BLAST is
an open sequence databasewithout any curator. Due to there being
no sequence of a standard strain of Prototheca zopﬁi var.
portoricensis in this database, we considered it as a suggestion
of the organism in question; however, it was further conﬁrmed by
other methods, including a phenotypic study. On the other hand, a
closely related species, Prototheca zopﬁi var. hydrocarbonea
(accession number AB097092.1), was used as the negative control
in our study, and our isolate did not present with a similar
sequence. Hence we could suppose that the sequencing of the 18S
SSU rDNA we conducted can differentiate different species in the
same genus.
4.2. Antifungal susceptibility
The susceptibility of the P. zopﬁi var. portoricensis isolates to the
antifungals amphotericin B (AMB), 5-ﬂucytosine (5FC), ﬂuconazole
(FCZ), ketoconazole (KTC), and itraconazole (ITZ) was examined in
vitro by broth microdilution according to the Clinical and
Laboratory Standards Institute (CLSI) M27-A2 guidelines.2 The
minimum inhibitory concentration (MIC) values were as follows:
AMB = 0.5 mg/ml; 5FC >64mg/ml; FCZ >64 mg/ml; ITZ >16mg/
ml; KTC = 4mg/ml. Disk diffusion susceptibility tests (ROSCO,
Denmark) revealed sensitivity to AMB and resistance to 5FC, FCZ,
KTC, and ITZ. These results correlated with the MICs obtained by
the CLSI. To date, there are no ofﬁcial guidelines for the
performance, interpretation, or quality control of in vitro
susceptibility tests for Prototheca species.3
4.3. Electron micrograph
A transmission electron micrograph (Philips-CM120) showed
spherical to oval sporangia with two to six endospores, which
reproduce asexually by internal separation and irregular cleavage.
Subsequent rupture and release of endospores with uneven
surfaces, mulberry-like or strawberry-like in shape, was observedin a scanning electron micrograph (HITACHI-S520). These ﬁndings
are in accordance with a previous report.4
4.4. Mouse model
Infectivity was studied in a mouse model. Eight-week-old male
CD-1 mice were obtained and randomly assigned to groups of two
mice each. The isolate was grown on SDA for 72 h. Doses for mouse
infection contained 1  106 cfu/ml, and 1ml aliquots (diluted in
sterile physiologic saline) were given by intraperitoneal injection in
experimentalmice. Controlmice received the samevolume of sterile
physiologic saline. After 4 weeks, mice were sacriﬁced under
anesthesia and internal organs were aseptically collected for
histopathological analysis. The samples were prepared and stained
by the PAS reaction. The organismswere seen in the necrotic areas of
lymphnodessurroundedbygranulomatous inﬂammation.However,
theywere not observed in the controlmice injectedwithphysiologic
saline. The pathogenicity of the isolate was then conﬁrmed.
4.5. Diagnosis and treatment
Based on the patient’s symptoms and microscopic evaluation,
cultures, and molecular analyses of the isolate, lymphadenitis due
to P. zopﬁi var. portoricensis was diagnosed. Intravenous ITZ was
given 200 mg twice a day for 2 days and then 200 mg once a day for
12 days, followed by ITZ 200 mg oral solution twice a day for 3
months. The patient improved signiﬁcantly within 4 weeks,
showing contraction of the previously enlarged lymph nodes.
However, after 6 months of taking ITZ, swollen lymph nodes were
again found on both sides of his neck, as well as in the
submaxillary, axillary, and inguinal regions. They were about
1.5  2 cm in size, without tenderness. The patient had no fever
and no complaints. Intravenous AMB was given in progressively
increasing doses for 10 days. The cumulative dose was 108 mg. As
his urea nitrogen and blood creatinine were abnormal, AMB was
substituted for oral ITZ; at that time, ultrasonography showed that
all enlarged lymph nodes had decreased in size. We continue to
follow the patient’s progress.
5. Discussion
Protothecosis is an uncommon human infection caused by
Prototheca, a rare cause of opportunistic infection. Prototheca spp
can be considered as saprophytes, and in spite of their frequency in
the environment, including in water, sewage, soil, potato skins,
cattle, dogs, and fruit bats, they are of low virulence andmay cause
chronic infection with low-grade inﬂammation in humans. The
pathogenesis of protothecosis is largely unknown. It is believed
that Prototheca species may infect humans through contact with
presumed sources, such as contaminated soil or water, by
traumatic inoculation with algae, or even through insect bites.5–
8 A Prototheca infection is exogenous or endogenous and usually
not transmissible.9 At present, P. zopﬁi, P. wickerhamii, P. stagnora,
Prototheca ulmea, and Prototheca blaschkeae sp. nov. are assigned to
the genus.10 Of these, the former two have been associated with
human disease,11 with P. wickerhamii being themore common. The
ﬁrst documented case of human protothecosis, which occurred in
1964, was a localized skin lesion in a rice farmer in Africa.12 Since
then, more than 117 cases have been reported.13 The most
common site of infection has been the skin and subcutaneous
tissues. Only a few cases of systemic protothecosis have been
documented. In China, a case of meningitis due to P. wickerhamii
has been reported.14 However, P. zopﬁi var. portoricensis as a
causative agent of human lymphadenitis has not been reported.
Here, we report a rare case of human lymphadenitis due to P. zopﬁi,
which was identiﬁed as P. zopﬁi var. portoricensis by molecular
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been classiﬁed into three clinical forms:6 cutaneous and/or
subcutaneous infections, synovitis of the olecranal bursa or other
ﬁbrous tissue, and systemic infection. In the 117 reported cases of
protothecosis, most have involved the skin and subcutaneous
tissues and have presented with erythematous nodules, plaques or
ulcers, verrucous or herpetiform lesions. Only a few cases of
systemic protothecosis have been documented.15 These systemic
cases were associated with cancer, AIDS, diabetes mellitus, renal
transplantation, steroids, or other immunosuppressive therapy.
The case we report here was an electrician, with normal cellular
and humoral immunity. No local or systemic immunosuppressive
factor was found in this case. In our patient, the exact source of the
Prototheca and the portal of entry of the organism are unknown.
We speculate that he was infected by contact with some materials
contaminatedwith Prototheca or by an unknown skin injury. It has
been reported that people who experience frequent mechanical
traumas are more susceptible to Prototheca infection.16 The
electrician in our study presumably had a greater chance of
exposure to water or other sources contaminated with Prototheca.
Most protothecal infections are attributed to local inoculation at
sites of skin defects or trauma and the incubation period has been
speculated to be several weeks.17 Protothecosis rarely demon-
strates spontaneous healing, with a typical course being chronic,
indolent, low-grade inﬂammation and slow progression. There is a
tendency towards a mild infection, which may be stable for long
periods,18–20 as occurred in the present case. Lymphadenitis due to
P. zopﬁi var. portoricensis has not yet been reported in an
immunocompetent case.
P. zopﬁi has consistently been divided into three variants or
biotypes (I to III). Based on sequence analysis of the 18S rRNA gene
and determination of cellular fatty acids, Roesler et al. suggested
that biotype III is a novel species, P. blaschkeae sp. nov. The P. zopﬁi
var. portoricensis reported here is currently biotype II of P.
zopﬁi.10,21 In China, only a few cases of infection caused by
Prototheca have been reported, and in particular P. zopﬁi var.
portoricensis has not been reported, probably due to the fact that
only a small number of qualiﬁed professionals are able to recognize
these organisms and also due to the unavailability of molecular
diagnostics. The real number of protothecosis cases may be more
than that reported in the literature.
Prototheca form creamy, yeast-like colonies on Sabouraud’s
medium when grown at 37 8C or 25 8C. The unicellular algae
measure from 4 to 30 mm and characteristically tend to form
endospores, which provide a basis for the identiﬁcation of the
isolate. Prototheca organisms must be differentiated from other
endosporulating organisms that undergo internal septation, in
particular those of Coccidioides immitis and Rhinosporidium seeberi.
Differentiation can be based on structural differences, with the
morula conﬁguration with symmetrical endospores characteristic
of Prototheca zopﬁi. A histological differential diagnosis should also
be made with mycoses presenting yeast-like forms in tissues,
which may be confused with the sporangia of Prototheca, such as
the capsule-deﬁcient form of Cryptococcus neoformans, Paracocci-
dioides brasiliensis, and Lacazia loboi. In contrast to Prototheca,
however, these fungi show budding and do not produce
endospores. P. brasiliensis produce various buds and the presence
of more than three is sufﬁcient for the histological diagnosis. L.
loboi reproduce by successive budding, forming characteristic
chains of cells connected to each other by prominences.
Krcmery22 reviewed 108 cases of human protothecosis and
suggested a 2.2% attributable mortality rate. The case we treatedwith intravenous ITZ improved. Intravenous ITZ has good clinical
efﬁcacy owing to its inhibitory action on the synthesis of an
ergosterol, a substance present in the Prototheca membrane.
Prototheca species show marked variability in their susceptibility
to imidazoles. The best treatment of protothecal infections remains
controversial, and various treatment regimens have been
attempted, but there has been no consistency in the clinical
response. Although protothecosis is still an uncommon form of
infection, its incidence worldwide may be higher than that
currently reported in the literature. Thus, clinicians should be
highly aware of any unknown cause of granulomatous lymphade-
nitis and should undertake an intensive histopathology, mycology
examination and even molecular analysis to rule out or conﬁrm a
potential Prototheca infection. In this way a prompt diagnosis and
treatment can be made.
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